கோரோ உயிர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Beyond COVID Vaccines, mRNA Could Transform Treatments
kjzz.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kjzz.org Daily Mail and Mail on Sunday newspapers.
The 24 Biotech Startups That Will Take Off in the Next Year, VCs Say
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies Geekwire 3 hrs ago © Provided by Geekwire Shape CEO Francois Vigneault. (Shape Photo)
Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million.
The company’s RNA editing technologies are spun out of the lab of co-founder Prashant Mali, a bioengineer at the University of California, San Diego who is on Shape’s scientific advisory board. Shape is also improving methods to deliver genetic material into cells.
“We continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases,” said CEO and co-founder Francois Vigneault, former VP of research at Juno Therapeutics, a Seattle flagship cell therapy company that was acquired by Celgene in 2018. Other Juno veterans at the company include Adrian Briggs, head of platform technologies, and David Huss, vice presi
Outside GC Expands Life Sciences Team to Meet Growing Industry Demand
Share Article
On-demand general counsel services firm experiences record growth in its life sciences practice
Our attorneys have deep industry experience as former GCs or senior in-house lawyers at life sciences companies, enabling them to provide judgment-level legal support at rates that are considerably less than a traditional law firm. BOSTON (PRWEB) May 27, 2021 Outside GC LLC, the nation’s leading provider of on-demand, in-house legal counsel services, has added six (6) new partners to its life sciences practice, essentially doubling the size of its team: John Caruso, Dara Reppucci and Sabune Winkler (New England); Michèle Linde (Mid-Atlantic); Perri Melnick (California) and Cyndi Baily (South). With this additional bench strength, Outside GC is well-positioned to continue supporting its thriving and growing portfolio of pharmaceutica
Published: May 13, 2021 By Alex Keown
Akouos, Inc. – Kathy Reape was named chief development officer of Boston-based Akouos. Reape most recently served as chief medical officer at Spark Therapeutics where she oversaw clinical development, pharmacovigilance, and medical affairs activities. Reape was a key member of the team responsible for the development and commercialization of Luxturna, the first FDA-approved in vivo gene therapy approved for an inherited retinal disease caused by mutations in both copies of the RPE65 gene. Prior to Spark, Reape was senior vice president of clinical development focusing on global brands research and development at Allergan and Actavis.
CARMAT – France-based CARMAT’s board of directors is reorganizing its governance and appointed three new directors. The company tapped Florent Battistella, David Coti and John B. Hernandez as directors. Battistella founded Nisima, a holding company, which holds stakes in various firms, notably
vimarsana © 2020. All Rights Reserved.